Gilead Sciences Inc (NASDAQ: GILD)
DRUGS - Biotechnology
Health Care
Stock price data as of
Closing price: $145.68
-
Support level$134.15
-
Resistance levelN/A
-
Beta0.4
-
RSI (14-day)72.0
- Volatility is forecast to fall over the next month.
- GILD is above its 200-day moving average, providing a measure of support for long positions.
- With RSI > 70, GILD is overbought. Odds slightly favor a short-term price reversal.
- Price broke above prior resistance level - a short-term bullish signal.
| 52-week low | 52-week high | Price as % of range |
|---|---|---|
| $110.56 | $155.80 | 80.4% |
| 200 day | 50 day | 20 day | 10 day |
|---|---|---|---|
| $133.72 | $134.10 | $140.05 | $145.77 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week7.5%
-
In the next month15.0%
-
In the next year53.6%
| Period | Value |
|---|---|
| Historical (5 year) | 24.4% |
| Last month | 26.2% |
| Current estimate | 27.6% |
| Next month forecast | 26.5% |